Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-033387
Filing Date
2026-03-23
Accepted
2026-03-23 16:59:27
Documents
49
Period of Report
2026-05-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A abbv-20260508xdef14a.htm   iXBRL DEF 14A 3133527
2 GRAPHIC abbv-20260508xdef14a_a001.jpg GRAPHIC 9585
3 GRAPHIC abbv-20260508xdef14a_a002.jpg GRAPHIC 2903
4 GRAPHIC abbv-20260508xdef14a_a003.jpg GRAPHIC 3106
5 GRAPHIC abbv-20260508xdef14a_a004.jpg GRAPHIC 2040
6 GRAPHIC abbv-20260508xdef14a_a005.jpg GRAPHIC 3499
7 GRAPHIC abbv-20260508xdef14a_a006.jpg GRAPHIC 3703
8 GRAPHIC abbv-20260508xdef14a_a007.jpg GRAPHIC 4669
9 GRAPHIC abbv-20260508xdef14a_a008.jpg GRAPHIC 2923
10 GRAPHIC abbv-20260508xdef14a_a009.jpg GRAPHIC 8364
11 GRAPHIC abbv-20260508xdef14a_a012.jpg GRAPHIC 3300
12 GRAPHIC abbv-20260508xdef14a_a013.jpg GRAPHIC 1714
13 GRAPHIC abbv-20260508xdef14a_a014.jpg GRAPHIC 1778
14 GRAPHIC abbv-20260508xdef14a_a019.jpg GRAPHIC 4128
15 GRAPHIC abbv-20260508xdef14a_a020.jpg GRAPHIC 5494
16 GRAPHIC abbv-20260508xdef14a_a021.jpg GRAPHIC 5753
17 GRAPHIC abbv-20260508xdef14a_a022.jpg GRAPHIC 11549
18 GRAPHIC abbv-20260508xdef14a_a025.jpg GRAPHIC 6532
19 GRAPHIC abbv-20260508xdef14a_a026.jpg GRAPHIC 7966
20 GRAPHIC abbv-20260508xdef14a_a027.jpg GRAPHIC 6975
21 GRAPHIC abbv-20260508xdef14a_a028.jpg GRAPHIC 5185
22 GRAPHIC abbv-20260508xdef14a_a029.jpg GRAPHIC 6058
23 GRAPHIC abbv-20260508xdef14a_a030.jpg GRAPHIC 6261
24 GRAPHIC abbv-20260508xdef14a_a031.jpg GRAPHIC 7584
25 GRAPHIC abbv-20260508xdef14a_a032.jpg GRAPHIC 6704
26 GRAPHIC abbv-20260508xdef14a_a033.jpg GRAPHIC 6514
27 GRAPHIC abbv-20260508xdef14a_a034.jpg GRAPHIC 6992
28 GRAPHIC abbv-20260508xdef14a_a035.jpg GRAPHIC 6848
29 GRAPHIC abbv-20260508xdef14a_a036.jpg GRAPHIC 5887
30 GRAPHIC abbv-20260508xdef14a_a050.jpg GRAPHIC 57015
31 GRAPHIC abbv-20260508xdef14a_a051.jpg GRAPHIC 60113
32 GRAPHIC abbv-20260508xdef14a_a064.jpg GRAPHIC 54496
33 GRAPHIC abbv-20260508xdef14a_a065.jpg GRAPHIC 50713
34 GRAPHIC abbv-20260508xdef14a_bg001.jpg GRAPHIC 116801
35 GRAPHIC abbv-20260508xdef14a_bg002.jpg GRAPHIC 127871
  Complete submission text file 0001104659-26-033387.txt   6729834

Data Files

Seq Description Document Type Size
36 EX-101.SCH abbv-20260508.xsd EX-101.SCH 5755
37 EX-101.DEF abbv-20260508_def.xml EX-101.DEF 6776
38 EX-101.LAB abbv-20260508_lab.xml EX-101.LAB 13303
39 EX-101.PRE abbv-20260508_pre.xml EX-101.PRE 9057
52 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20260508xdef14a_htm.xml XML 751161
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35565 | Film No.: 26783100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)